Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma

We have previously shown that ablative radiotherapy (A-RT) with a biologically effective dose (BED(10)) ≥ 80.5 Gy for patients with unresectable intrahepatic cholangiocarcinoma (ICC) is associated with longer survival. Despite recent large-scale sequencing efforts in ICC, outcomes following RT based...

Descripción completa

Detalles Bibliográficos
Autores principales: De, Brian, Abu-Gheida, Ibrahim, Patel, Aashini, Ng, Sylvia S. W., Zaid, Mohamed, Thunshelle, Connor P., Elganainy, Dalia, Corrigan, Kelsey L., Rooney, Michael K., Javle, Milind, Raghav, Kanwal, Lee, Sunyoung S., Vauthey, Jean-Nicolas, Tzeng, Ching-Wei D., Tran Cao, Hop S., Ludmir, Ethan B., Minsky, Bruce D., Smith, Grace L., Holliday, Emma B., Taniguchi, Cullen M., Koong, Albert C., Das, Prajnan, Koay, Eugene J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703854/
https://www.ncbi.nlm.nih.gov/pubmed/34945742
http://dx.doi.org/10.3390/jpm11121270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703854/
https://www.ncbi.nlm.nih.gov/pubmed/34945742
http://dx.doi.org/10.3390/jpm11121270

Ejemplares similares